Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Current Opinion in Drug Discovery & Development
|
June 13, 2002
Fragment analysis in small molecule discovery
Cédric Merlot, Daniel Domine, Dennis J Church
Drug Discovery Today
|
July 10, 2003
Chemical substructures in drug discovery
Cédric Merlot, Daniel Domine, Christophe Cleva, et al.
The Journal of Biological Chemistry
|
October 13, 2005
Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia
Claudio Hetz, Pierre-Alain Vitte, Agnes Bombrun, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
Design, synthesis, and biological activity of novel, potent, and selective (benzoylaminomethyl)thiophene sulfonamide inhibitors of c-Jun-N-terminal kinase
Thomas Rückle, Marco Biamonte, Tania Grippi-Vallotton, et al.
Journal of Medicinal Chemistry
|
November 24, 2005
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists
Anna Quattropani, Jérôme Dorbais, David Covini, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Current Opinion in Drug Discovery & Development
|
June 13, 2002
Fragment analysis in small molecule discovery
Cédric Merlot, Daniel Domine, Dennis J Church
Drug Discovery Today
|
July 10, 2003
Chemical substructures in drug discovery
Cédric Merlot, Daniel Domine, Christophe Cleva, et al.
The Journal of Biological Chemistry
|
October 13, 2005
Bax channel inhibitors prevent mitochondrion-mediated apoptosis and protect neurons in a model of global brain ischemia
Claudio Hetz, Pierre-Alain Vitte, Agnes Bombrun, et al.
Journal of Medicinal Chemistry
|
December 24, 2004
Design, synthesis, and biological activity of novel, potent, and selective (benzoylaminomethyl)thiophene sulfonamide inhibitors of c-Jun-N-terminal kinase
Thomas Rückle, Marco Biamonte, Tania Grippi-Vallotton, et al.
Journal of Medicinal Chemistry
|
November 24, 2005
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists
Anna Quattropani, Jérôme Dorbais, David Covini, et al.
Page
of 1